These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4370673)

  • 1. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of chlorpropamide action in patients with diabetes insipidus.
    Murase T; Yoshida S
    J Clin Endocrinol Metab; 1973 Jan; 36(1):174-7. PubMed ID: 4681880
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of exogenous 3':5'-adenosine monophosphate on urinary output in children with vasopressin-resistant diabetes insipidus.
    Proesmans W; Eggermont E; Vanderschueren-Lodeweyckx M; Tiddens H; Eeckels R
    Pediatr Res; 1975 May; 9(5):509-12. PubMed ID: 166349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a defect in the formation of adenosine 3',5'-monophosphate in vasopressin-resistant diabetes insipidus.
    Bell NH; Clark CM; Avery S; Sinha T; Trygstad CW; Allen DO
    Pediatr Res; 1974 Apr; 8(4):223-30. PubMed ID: 4362729
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of vasopressin and renal prostaglandins in the homozygous diabetes insipidus rat.
    Dunn MJ; Kinter LB; Beeuwkes R; Shier D; Greeley HP; Valtin H
    Adv Prostaglandin Thromboxane Res; 1980; 7():1009-13. PubMed ID: 7369014
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
    Uttley WS; Atkinson B; Adams A; Shirling D
    J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
    Aronson AS; Andersson KE; Bergstrand CG; Mulder JL
    Acta Paediatr Scand; 1973 Mar; 62(2):133-40. PubMed ID: 4691456
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oral antidiabetic agents on diuresis in diabetes insipidus of the vasopressin-responsive and the nephrogenous types.
    László FA; Czakó L
    Acta Med Acad Sci Hung; 1971; 28(2):196-204. PubMed ID: 5148333
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorpropamide in diabetes insipidus in childhood.
    Rosenbloom AL
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):671-9. PubMed ID: 5000713
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidiuretic effect of 1-propyl-3-p-chlorobenzene-sulfonylurea (chlorpropamide).
    Reforzo-Membrives J; Moledo LI; Lanaro AE; Megías A
    J Clin Endocrinol Metab; 1968 Mar; 28(3):332-6. PubMed ID: 5644194
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of vasopressin, water load and aminophylline on adenosine 3', 5'-phosphate in human urine.
    Takahashi K
    Kobe J Med Sci; 1971 Mar; 17(1):17-33. PubMed ID: 4334309
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of chlorpropamide in diabetes insipidus in children.
    Ehrlich RM; Kooh SW
    Pediatrics; 1970 Feb; 45(2):236-45. PubMed ID: 5413385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic use of chlorpropamide antidiuresis in diabetes insipidus].
    Schneider D; Fleischmann J; Haase R
    Z Gesamte Inn Med; 1972 Jan; 27(1):31-5. PubMed ID: 4335601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diversity of current treatments of diabetes insipidus].
    Schaison G
    Presse Med (1893); 1971 Mar; 79(13):561-4. PubMed ID: 4930499
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of chlorpropamide action in diabetes insipidus.
    Miller M; Moses AM
    J Clin Endocrinol Metab; 1970 Apr; 30(4):488-96. PubMed ID: 5435288
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chlorpropamide on urinary excretion of water and solute in patients with diabetes insipidus and on water flow across isolated toad bladder.
    Danisi G; Genta EN; Timoner J; Marcondes M
    J Clin Endocrinol Metab; 1970 Apr; 30(4):528-30. PubMed ID: 5435291
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of cyclic adenosine 3'-5' monophosphate in central diabetes insipidus patients treated with certain antidiuretic drugs.
    Pruszczyński W
    Endokrynol Pol; 1978; 29(6):517-25. PubMed ID: 214296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chlorpropamide in diabetes insipidus].
    Uhlich E; Loeschke K
    Minerva Med; 1973 May; 64(31):1702-4. PubMed ID: 4351789
    [No Abstract]   [Full Text] [Related]  

  • 20. A potential danger of oral chlorpropamide therapy: impaired excretion of a water load.
    Linshaw MA; Sey M; DiGeorge AM; Gruskin AB
    J Clin Endocrinol Metab; 1972 Mar; 34(3):562-9. PubMed ID: 5011260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.